Search research articles
Contact Us
Filters
Showing results (111-120 of 397) with videos related to
Page
of 40
Sort By:
Journal for Immunotherapy of Cancer
|
August 8, 2025
Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors
Omar Pacha, Anisha B Patel, Jonathan L Curry, et al.
Journal of Human Evolution
|
November 13, 2007
Anatomy of the bony pelvis of a relatively large-bodied strepsirrhine primate from the late middle Eocene Pondaung Formation (central Myanmar)
Laurent Marivaux, K Christopher Beard, Yaowalak Chaimanee, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 15, 2020
Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis
Akanksha Srivastava, Graciela M Nogueras Gonzalez, Yimin Geng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 29, 2012
Survival of 1,181 patients in a phase I clinic: the MD Anderson Clinical Center for targeted therapy experience
Jennifer Wheler, Apostolia M Tsimberidou, David Hong, et al.
Scientific Reports
|
February 12, 2021
Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial
Jeffrey A How, Amir A Jazaeri, Pamela T Soliman, et al.
Oncotarget
|
June 27, 2013
Germline PTPRD mutations in Ewing sarcoma: biologic and clinical implications
Yunyun Jiang, Filip Janku, Vivek Subbiah, et al.
Investigational New Drugs
|
January 31, 2013
A phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies
Aung Naing, Roger Cohen, Grace K Dy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2013
Phase I study of BIIB028, a selective heat shock protein 90 inhibitor, in patients with refractory metastatic or locally advanced solid tumors
David Hong, Rabih Said, Gerald Falchook, et al.
Cancer
|
August 9, 2011
Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center
Ignacio Garrido-Laguna, Filip Janku, Christos Vaklavas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2012
Insulin growth factor-receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with refractory Ewing's sarcoma family tumors
Aung Naing, Patricia LoRusso, Siqing Fu, et al.
Page
of 40
Search research articles
Search
Showing results (111-120 of 397) with videos related to
Sort By:
Page
of 40
Journal for Immunotherapy of Cancer
|
August 8, 2025
Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors
Omar Pacha, Anisha B Patel, Jonathan L Curry, et al.
Journal of Human Evolution
|
November 13, 2007
Anatomy of the bony pelvis of a relatively large-bodied strepsirrhine primate from the late middle Eocene Pondaung Formation (central Myanmar)
Laurent Marivaux, K Christopher Beard, Yaowalak Chaimanee, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 15, 2020
Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis
Akanksha Srivastava, Graciela M Nogueras Gonzalez, Yimin Geng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 29, 2012
Survival of 1,181 patients in a phase I clinic: the MD Anderson Clinical Center for targeted therapy experience
Jennifer Wheler, Apostolia M Tsimberidou, David Hong, et al.
Scientific Reports
|
February 12, 2021
Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial
Jeffrey A How, Amir A Jazaeri, Pamela T Soliman, et al.
Oncotarget
|
June 27, 2013
Germline PTPRD mutations in Ewing sarcoma: biologic and clinical implications
Yunyun Jiang, Filip Janku, Vivek Subbiah, et al.
Investigational New Drugs
|
January 31, 2013
A phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies
Aung Naing, Roger Cohen, Grace K Dy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2013
Phase I study of BIIB028, a selective heat shock protein 90 inhibitor, in patients with refractory metastatic or locally advanced solid tumors
David Hong, Rabih Said, Gerald Falchook, et al.
Cancer
|
August 9, 2011
Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center
Ignacio Garrido-Laguna, Filip Janku, Christos Vaklavas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2012
Insulin growth factor-receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with refractory Ewing's sarcoma family tumors
Aung Naing, Patricia LoRusso, Siqing Fu, et al.
Page
of 40